1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ly 53857 in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ly 53857) | Trials (ly 53857) | Recent Studies (post-2010) (ly 53857) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 133 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silbaugh, SA; Stengel, PW | 1 |
Baer, PG; Cagen, LM | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ly 53857
Article | Year |
---|---|
Reversal of A23187-induced airway constriction in the guinea pig.
Topics: Airway Obstruction; Airway Resistance; Albuterol; Animals; Calcimycin; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Leukotrienes; Lung Compliance; Male; Platelet Activating Factor; Serotonin; Thromboxane A2 | 1989 |
Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
Topics: Alprazolam; Animals; Blood Pressure; Dogs; Ergolines; Female; Kidney; Male; Meclofenamic Acid; Methysergide; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Saralasin; Vascular Resistance; Vasoconstriction | 1987 |